HIV-Associated Neurological Disorders: A Guide to Pharmacotherapy

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.2, 2012-02, pp. : 123-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of CNS Transporters in the Pharmacotherapy of HIV-1 Associated Neurological Disorders

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1543-1563

Bentham Science Publishers

Access to resources Recommend Favorite

Gabexate ± octreotide for HIV-associated pancreatic disorders

Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

HTLV-1 Associated Neurological Disorders

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 12, 2017-03 ,pp. : 1320-1330

Bentham Science Publishers

Access to resources Recommend Favorite

Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2706-2714

Bentham Science Publishers

Access to resources Recommend Favorite